Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 04 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-04-2021-9

Cadila Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2021, titled "Zydus announces completion of Phase-I trials of ZY19489 A single dose cure for Malaria in collaboration with MMV".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases